US pharma, Brazilian IP groups differ on US tariff response
Organizations representing the American pharmaceutical industry and IP policy groups encouraged the Office of the US Trade Representative this week to move forward with punitive action against Brazil following a Section...To view the full article, register now.
Already a subscriber? Click here to view full article